Shlomi Madar, CEO of SpotitEarly, discusses the company's noninvasive test using a breath sample, which is analyzed by specially trained dogs capable of identifying unique cancer-related scent signatures combined with AI technology. Global AI By HIMSS TV | February 23, 2026 | 9:45 AM Tags: cancer diagnostics, clinical decision support, clinical AI